UBS Group »

Kala Bio shares owned by UBS Group

Quarter-by-quarter ownership of Kala Bio shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Kala Bio

Tip: Access up to 7 years of quarterly data

All positions including Kala Bio held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Bio by UBS Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $16k 9.1k 1.73

More positions owned by UBS Group

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for UBS Group

Top funds holding Kala Bio

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Northern Trust
Qube Research & Technologies
Goldman Sachs Group
UBS Group
Tower Research Capital
Barclays
Caitong International Asset Management
International Assets Investment Management

View all funds holding Kala Bio